Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Immunological Reviews|April 1, 1997
A vision of cell death: insights into immune privilegeT A Ferguson, T S GriffithCurrent Opinion in Immunology|October 31, 1998
TRAIL: a molecule with multiple receptors and control mechanismsT S Griffith, D H LynchMolecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirusT S Griffith, E L BroghammerThe Journal of Experimental Medicine|May 1, 1994
Regulation of contact hypersensitivity by interleukin 10T A Ferguson, P Dube, T S GriffithCancer Gene Therapy|February 4, 2006
Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitorsR L VanOosten, J K Earel, T S GriffithJournal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
Neuropeptides modulate immune deviation induced via the anterior chamber of the eyeT A Ferguson, S Fletcher, J Herndon, et al.The Journal of Experimental Medicine|October 19, 1999
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)N A Fanger, C R Maliszewski, K Schooley, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosisA Algeciras-Schimnich, T S Griffith, D H Lynch, et al.Apoptosis : an International Journal on Programmed Cell Death|January 24, 2004
Induction of necrotic tumor cell death by TRAIL/Apo-2LT J Kemp, J-S Kim, S A Crist, et al.International Immunology|October 1, 1995
The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eyeT S Griffith, J M Herndon, J Lima, et al.Pageof 3